晚期囊袋内人工晶状体脱位手术患者的青光眼与眼压:一项随机临床试验
这项前瞻性随机平行组临床试验在大学诊所纳入104例晚期囊袋内人工晶状体脱位患者,随机分配至巩膜缝线固定复位组(54例)或后瞳孔虹膜夹持晶状体置换组(50例),主要结局为术后6个月眼压变化。总体眼压从术前18.0±6.2 mmHg降至术后6个月15.7±4.8 mmHg(P<.001),置换组眼压变化-3.8±6.4 mmHg(P<.001),复位组为-1.2±5.8 mmHg(P=.18),组间差异P=.05。作者结论认为脱位手术后眼压下降在置换组似乎更明显,但许多患者的高眼压并未因脱位手术而解决,术后常需增加降眼压治疗。
要点
- 总体眼压从术前18.0±6.2 mmHg降至术后6个月15.7±4.8 mmHg(P<.001)。
- 置换组眼压变化-3.8±6.4 mmHg(P<.001),复位组-1.2±5.8 mmHg(P=.18),组间差异P=.05。
- 术后两组分别有28%和21%的患者需加用降眼压药物、激光或滤过手术等治疗。
核心结论
- 该试验显示晚期囊袋内人工晶状体脱位手术后眼压下降,置换组的下降似乎更明显。
- 然而许多患者的相关高眼压并未因脱位手术而解决,术后病程中常需增加降眼压治疗。
研究设计与样本
- 前瞻性、随机、平行组临床试验,在大学诊所纳入104例(眼)晚期囊袋内人工晶状体脱位患者。
- 患者随机分配至巩膜缝线固定复位组(n=54)或后瞳孔虹膜夹持晶状体置换组(n=50)。
- 主要结局指标为术后6个月眼压变化。
主要发现
- 总体眼压术前为18.0±6.2 mmHg,术后6个月为15.7±4.8 mmHg(P<.001)。
- 复位组眼压变化为-1.2±5.8 mmHg(P=.18),置换组为-3.8±6.4 mmHg(P<.001),组间差异P=.05。
- 术前62例患者有既往青光眼(n=39)或高眼压(≥22 mmHg)伴疑似青光眼(n=23),其中部分患者需术前降眼压治疗。
- 术后两组分别有28%和21%的患者需加用降眼压药物治疗、辅助激光小梁成形术、睫状体二极管激光或滤过手术。
- 两组分别有0例和3例患者停用降眼压药物。
关键数值与推荐
- 总体眼压术前18.0±6.2 mmHg vs 术后6个月15.7±4.8 mmHg(P<.001)。
- 复位组眼压变化-1.2±5.8 mmHg(P=.18)vs 置换组-3.8±6.4 mmHg(P<.001),组间差异P=.05。
- 术前高眼压定义为≥22 mmHg。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
PURPOSE: To compare intraocular pressure (IOP) and IOP-lowering treatment requirements in patients with late in-the-bag intraocular lens (IOL) dislocation operated with 2 different methods, and to assess whether an IOP decrease after surgery can be expected. DESIGN: Prospective, randomized, parallel-group clinical trial. METHODS: In our university clinic, 104 patients (eyes) were randomly assigned to IOL repositioning by scleral suturing (n = 54) or IOL exchange with a retropupillar iris-claw lens (n = 50). The main outcome measure was 6-month postoperative IOP change. RESULTS: Overall IOP was 18.0 ± 6.2 mm Hg before surgery and 15.7 ± 4.8 mm Hg 6 months after surgery (P < .001). IOP changed by -1.2 ± 5.8 mm Hg (P = .18) in the Repositioning group and -3.8 ± 6.4 mm Hg (P < .001) in the Exchange group (group difference: P = .05). Before surgery, 62 patients had either preexisting glaucoma (n = 39) or high IOP (≥22 mm Hg) with suspected glaucoma (n = 23), of whom several required preoperative IOP-lowering treatment. In the postoperative period, 28% and 21% of the patients in each operation group, respectively, required IOP-lowering treatment with glaucoma medications added, adjunctive laser trabeculoplasty, cyclodiode laser, or filtering surgery. Only 0 and 3 patients, respectively, discontinued their IOP-lowering medication. CONCLUSIONS: This trial showed an IOP decrease after late in-the-bag IOL dislocation surgery that seemed to be more pronounced with IOL exchange. However, associated high IOP was not resolved by dislocation surgery in many patients, and increased IOP-lowering treatment in the postoperative course was commonly required.
引用
- Kristianslund O, Råen M, Østern AE, et al. Glaucoma and Intraocular Pressure in Patients Operated for Late In-the-bag Intraocular Lens Dislocation: A Randomized Clinical Trial. Am J Ophthalmol. 2017. PMID: 28167054. doi:10.1016/j.ajo.2017.01.026
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。